Summary
- Current Price
- As of today, GH price is $177.25, up +0.45% on
- Current Price All-Time High
- GH price is currently -3.41% below its historical high of $183.51 set on
- Market Cap
- GH current market cap is $24B, up +217.53% over the past 365 days
- Revenue
- GH current annual revenue is $982.02M, up +32.88% year-over-year
- Next Earnings
- The next earnings release for GH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Guardant Health, Inc. |
| Ticker | NASDAQ: GH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | guardanthealth.com |
| Employees | 1,999 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $177.25 | |
| Price, 1D Change | +0.45% | |
| Market Cap | $24B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.91 | |
| Revenue | $982.02M | |
| Revenue, 1Y Change | +32.88% | |
| EPS | -$3.32 | |
| EPS, 1Y Change | +6.60% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$3.32 | |
| EPS Estimate | -$1.46 | N/A |
| EPS Est. Change | +55.89% | N/A |
| Revenue | $982.02M | |
| Revenue Estimate | $1.36B | N/A |
| Revenue Est. Change | +38.25% | N/A |
| Current Price | $177.25 | |
| Price Target | $197.50 | - |
| Price Tgt. Change | +11.42% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.99 | -$3.56 | -78.95% | |
| -$1.81 | -$3.32 | -83.88% | |
| -$1.46 | N/A | +55.89% | |
| -$0.40 | N/A | +88.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $729.04M | $739.02M | +1.37% | |
| $972.05M | $982.02M | +1.03% | |
| $1.36B | N/A | +38.25% | |
| $1.84B | N/A | +87.34% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +194.53% | |
| Price, 3Y | +574.98% | |
| Market Cap, 1Y | +217.53% | |
| Market Cap, 3Y | +669.83% | |
| Revenue, 1Y | +32.88% | |
| Revenue, 3Y | +118.45% | |
| EPS, 1Y | +6.60% | |
| EPS, 3Y | +48.17% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $177.25 | |
| SMA 200 | $122.06 | |
| SMA 50 | $162.76 | |
| EMA 200 | $126.94 | |
| EMA 50 | $162.50 | |
| MACD | $4.47 | |
| Beta | 0.91 | |
| ATR | $7.89 | |
| 14-Day RSI | 59.44 | |
| 10-Day Volatility | 50.26% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $982.02M | |
| EPS | -$3.32 | |
| Gross Profit | $633.01M | |
| Gross Margin | 64.46% | |
| Operating Income | -$436.30M | |
| Operating Margin | -44.43% | |
| Net Income | -$416.28M | |
| Net Margin | -42.39% | |
| EBITDA | -$396.56M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | -17.22 | |
| 4.84 | ||
| 4.56 | ||
| - | ||
| 4 | ||
| 5.14 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 20.10 | ||
| -106.73 | ||
| -56.65 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | -$99.31M | |
| $1.20B | ||
| $2.01B | ||
| $1.47B | ||
| $2.11B | ||
| $302.73M | ||
| Total Debt | $1.71B | |
| $27.68M | ||
| $54.44M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.40B | ||
| $1.07B | ||
| $349.01M | ||
| $706.07M | ||
| $39.74M | ||
| $0.00 | ||
| -$1.26M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$184.76M | ||
| -$627.20M | ||
| $671.13M | ||
| Capex | $48.31M | |
| -$233.07M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| Rothschild & Co | ||
| BTIG | → | |
| Stephens & Co. | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Stifel | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| Mizuho | → |
Analyst sentiment
Institutional ownership
No data
Screeners with GH
FAQ
- What is the ticker symbol for Guardant Health, Inc.?
- The ticker symbol for Guardant Health, Inc. is NASDAQ:GH
- Does Guardant Health, Inc. pay dividends?
- No, Guardant Health, Inc. does not pay dividends
- What sector is Guardant Health, Inc. in?
- Guardant Health, Inc. is in the Healthcare sector
- What industry is Guardant Health, Inc. in?
- Guardant Health, Inc. is in the Diagnostics & Research industry
- What country is Guardant Health, Inc. based in?
- Guardant Health, Inc. is headquartered in United States
- When did Guardant Health, Inc. go public?
- Guardant Health, Inc. initial public offering (IPO) was on October 4, 2018
- Is Guardant Health, Inc. in the S&P 500?
- No, Guardant Health, Inc. is not included in the S&P 500 index
- Is Guardant Health, Inc. in the NASDAQ 100?
- No, Guardant Health, Inc. is not included in the NASDAQ 100 index
- Is Guardant Health, Inc. in the Dow Jones?
- No, Guardant Health, Inc. is not included in the Dow Jones index
- When was Guardant Health, Inc. last earnings report?
- Guardant Health, Inc.'s most recent earnings report was on July 30, 2026
- When does Guardant Health, Inc. report earnings?
- The next expected earnings date for Guardant Health, Inc. is October 28, 2026
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628026000013/0001576280-26-000013-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh
